LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (drug combination treatments). Dataset 1 of 2: Cell count and normalized growth rate inhibition values. - Dataset (ID:20259)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol 1 Concentration | Small Mol 1 Conc Unit | Small Molecule 2 | Small Mol 2 Concentration | Small Mol 2 Conc Unit | Biological Replicate | Technical Replicate | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Alpelisib | 0.0400 | uM | NVP-TAE684 | 0.3704 | uM | 1 | 2 | 2751 | 7145 | 4996 | 2.0301 |
| BT-20 | Lapatinib | 3.3333 | uM | 0 | uM | 1 | 2 | 2751 | 7250 | 4996 | 2.0819 | |
| BT-20 | NVP-TAE684 | 0.3704 | uM | 0 | uM | 1 | 1 | 2751 | 7393 | 4757 | 2.4934 | |
| BT-20 | Alpelisib | 0.0400 | uM | NVP-TAE684 | 0.3704 | uM | 1 | 1 | 2751 | 7412 | 4757 | 2.5048 |
| BT-20 | Lapatinib | 1.9245 | uM | 0 | uM | 1 | 1 | 2751 | 7730 | 4757 | 2.6962 |